Prof Bill Lockley wins Melvin Calvin Award
Thursday 27 September 2012
At the recent triennial symposium of the International Isotope Society held in Heidelberg , Germany, 9th-12th Sept 2012, Professor Bill Lockley of the Department of Chemistry (FEPS) was selected as the recipient of the society’s Melvin Calvin Award.
This is the highest international honour awarded by the society and is given at three yearly intervals to acknowledge “outstanding contributions to the field of isotopes”. In the associated Melvin Calvin Lecture Prof. Lockley covered aspects of his research in the following areas: applications of 3H and 2H in the elucidation of fundamental biosynthetic pathways, development of a range of novel metal catalysts for labelling organic compounds with hydrogen isotopes and the application of rapid 3H-labelling strategies to accelerate and improve pharmaceutical R&D projects.
This is the second time a Surrey academic has been chosen to receive the award. In 2003 Prof. John Jones of the Department of Chemistry was selected for his contributions on the use of tritium in the study of the reaction kinetics of carbon acids and for his part in the development of tritium-NMR.
Previous recipients of the Award
1985 Prof. Melvin Calvin (Lawrence Berkeley Lab, USA) for his isotopic work on the elucidation of carbon fixation intermediates during the dark reactions of photosynthesis.
1991 Dr. Anthony Evans (Amersham International, UK) for his extensive contributions to the broad development of 3H-chemistry.
1994 Prof. Chin-Tzu Peng (Univ. California, USA) for his investigations of the fundamental mechanisms of isotopic exchange reactions.
1997 Prof. Alfred Wolf (Brookhaven National Laboratory, USA) for the development of hot atom chemistry.
2003 Prof. John Jones (Univ. Surrey, UK ) for the use of tritium in the study of the reaction kinetics of carbon acids and the development of tritium-NMR
2006 Joint award to Prof. Bengt Langsgtrom (Univ. Uppsala, Sweden) for his work with the positron emission tomography of 11C and to Prof. Michael Welch (Univ. Washington, USA) for his contributions to applications of short lived emitters in nuclear medicine.
2009 Dr J Richard Heys (AstraZeneca/ GSK, USA) for his development of ortho-3H-exchange labelling methodologies and their applications in pharmaceutical R&D.
